Your browser doesn't support javascript.
loading
Somatostatin receptor scintigraphy during treatment with lanreotide in patients with neuroendocrine tumors.
Janson, E T; Kälkner, K M; Eriksson, B; Westlin, J E; Oberg, K.
Affiliation
  • Janson ET; Department of Medical Sciences, University Hospital, Uppsala, Sweden. Eva.TiensuuvJanson@medicin.uu.se
Nucl Med Biol ; 26(8): 877-82, 1999 Nov.
Article in En | MEDLINE | ID: mdl-10708300
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Peptides, Cyclic / Somatostatin / Octreotide / Receptors, Somatostatin / Neuroendocrine Tumors / Radiopharmaceuticals / Pentetic Acid / Antineoplastic Agents Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Nucl Med Biol Journal subject: BIOLOGIA / MEDICINA NUCLEAR Year: 1999 Document type: Article Affiliation country: Suecia Country of publication: Estados Unidos
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Peptides, Cyclic / Somatostatin / Octreotide / Receptors, Somatostatin / Neuroendocrine Tumors / Radiopharmaceuticals / Pentetic Acid / Antineoplastic Agents Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Nucl Med Biol Journal subject: BIOLOGIA / MEDICINA NUCLEAR Year: 1999 Document type: Article Affiliation country: Suecia Country of publication: Estados Unidos